NeuroStar® Expands “Tap Into Possibility” Campaign in Honor of Mental Health Awareness Month
A Media Snippet accompanying this announcement is available by clicking on the image or link below:
“The patient journey is at the heart of everything we do. We understand that depression can be debilitating, and we want to be part of the solution,” said
The “Tap Into Possibility” campaign first launched in 2022 to raise awareness about the impact of major depressive disorder (MDD) on millions of people and the possibilities for patients after trying multiple treatment options to no avail. The new phase of the campaign will feature patient stories from Cara, Daniel, Lisa, and Jess to authentically illustrate their journey from depression to recovery:
- "The truth is, I am enough. I am worth it, and I am worthy. As cliche as it sounds, NeuroStar has completely changed my life. I am a different person. I found me. I found a better version of myself. I found love that I didn't know existed. It's been an incredible journey, and I am forever grateful. Because I know the alternative is much worse." – Cara
- "Post-treatment, NeuroStar has helped me get back to living life, enjoying life. I wake up smiling. I get to see my daughter how a father should see their kid. NeuroStar gave that back to me." – Daniel
- "With depression, you live in a fog and don't realize it. You don't know that you're not seeing the world with the same eyes as someone who does not have depression. I've been two years free from depression, and I have not needed additional treatments. Some people do, and that's okay. Because no two people are the same." – Lisa
- "I've had a lot of different cocktails of medications over the past 15 years. They would work for a little while, and then I would go back into a depressive episode. NeuroStar has impacted every single aspect of my life. I can live my life again because of this treatment." - Jess
The campaign featuring inspiring narratives from patient advocates will launch in May and extend throughout the year across owned channels and NeuroStar's website. An exciting initiative of the expanded campaign will include the creation of a web-based story submission portal that will make it easy for additional patients to share their voices and experiences with others. For more information about NeuroStar, please visit neurostar.com.
About
Media Contact:
EvolveMKD
646.517.4220
NeuroStar@evolvemkd.com

Source: Neuronetics